Lexicon Pharmaceuticals (LXRX) Return on Sales Growth (5y) (2015 - 2026)
Lexicon Pharmaceuticals (LXRX) Return on Sales Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | Lexicon Pharmaceuticals | 886.53 Mn | 715.87 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.00 |
| Dec 31, 2025 | 25.00 |
| Sep 30, 2025 | 5.00 |
| Jun 30, 2025 | 2,810.00 |
| Mar 31, 2025 | -14.00 |
| Dec 31, 2024 | 4.00 |
| Sep 30, 2024 | -40.00 |
| Jun 30, 2024 | -7.00 |
| Mar 31, 2024 | -37.00 |
| Dec 31, 2023 | -67.00 |
| Sep 30, 2023 | -366.00 |
| Jun 30, 2023 | -174.00 |
| Mar 31, 2023 | -3,266.00 |
| Dec 31, 2022 | -3,005.00 |
| Sep 30, 2022 | -2,839.00 |
| Jun 30, 2022 | -744.00 |
| Sep 30, 2021 | -340.00 |
| Jun 30, 2021 | 191.00 |
| Mar 31, 2021 | -60.00 |
| Dec 31, 2020 | -28.00 |